HemaChrome
PrivateLast Round
Grant
Feb 15, 2023
Total Funding Raised
$425,000
Company Overview
HemaChrome is a digital health company that provides a non-invasive smartphone-based platform for measuring blood hemoglobin levels.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Telemedicine, Clinical Trials, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HemaChrome Comparables
Compare HemaChrome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Monere | 88% | |
| Sanguina, Inc. | 84% | |
| EzeRx Health Tech | 70% |
HemaChrome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 15, 2023 | ||||
| Accelerator | Nov 8, 2021 | ||||
| Grant | Nov 4, 2020 |
HemaChrome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Biomedical Imaging and Bioengineering | Grant |
| NIH RADx | Grant |
| Purdue Foundry | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 15, 2023
$20K grant received from NIH RADx.
- Nov 4, 2020
$400K grant from the National Institute of Biomedical Imaging and Bioengineering.
HemaChrome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about HemaChrome's valuation, stock price, and market status.
Is HemaChrome a public or private company?
HemaChrome is a private company.
What is the current stock price of HemaChrome?
HemaChrome is a private company with no public stock price. No recent secondary market data is available.
How much is HemaChrome worth (valuation)?
Valuation information for HemaChrome is not publicly available.
Can I buy HemaChrome stock?
HemaChrome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was HemaChrome's last funding round?
HemaChrome's most recent funding round was Grant on February 15, 2023.
Who are the main investors in HemaChrome?
Key investors in HemaChrome include National Institute of Biomedical Imaging and Bioengineering, NIH RADx, Purdue Foundry.
Will HemaChrome IPO soon?
No public IPO plans have been announced for HemaChrome.
How can I track HemaChrome secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor HemaChrome's secondary market activity and sign up for updates.